Inventor
ANDERSON NIALL ANDREW
GB14 patents
Patents
14 patentsUS10513517B2Dec 24, 2019
Naphthyridine derivatives as alpha V beta 6 integrin antagonists for the treatment of E.G. fibrotic diseases
GLAXOSMITHKLINE IP DEV LTD11 citations82
US10023568B2Jul 17, 2018
Naphthyridine derivatives useful as αvβ6 integrin antagonists
GLAXOSMITHKLINE IP DEV LTD5 citations80
US10144733B2Dec 4, 2018
Naphthyridine derivatives as alpha v beta 6 integrin antagonists for the treatment of E.G. fibrotic diseases
GLAXOSMITHKLINE IP DEV LTD5 citations71
US10004724B2Jun 26, 2018
Compounds alpha v beta 6 integrin antagonists
GLAXOSMITHKLINE IP DEV LTD2 citations71
US10487080B2Nov 26, 2019
Naphthyridines as integrin antagonists
GLAXOSMITHKLINE IP DEV LTD3 citations70
US10000489B2Jun 19, 2018
Compounds αvβ6 integrin antagonists
GLAXOSMITHKLINE IP DEV LTD5 citations70
US9956209B2May 1, 2018
Compounds αv β6 integrin antagonists
GLAXOSMITHKLINE IP DEV LTD4 citations70
US10899716B2Jan 26, 2021
Heterocyclic amides as kinase inhibitors
GLAXOSMITHKLINE IP DEV LTD2 citations69
US10590085B2Mar 17, 2020
Heterocyclic amides as kinase inhibitors
GLAXOSMITHKLINE IP DEV LTD3 citations69
US10450312B2Oct 22, 2019
Naphthyridine derivatives useful as alpha-V-beta-6 integrin antagonists
GLAXOSMITHKLINE IP DEV LTD3 citations69
US11485710B2Nov 1, 2022
Heterocyclic amides as kinase inhibitors
GLAXOSMITHKLINE IP DEV LTD0 citations59
US10342783B2Jul 9, 2019
Compounds αvβ6 integrin antagonists
GLAXOSMITHKLINE IP DEV LTD1 citations59
US10793559B2Oct 6, 2020
Chemical compounds
GLAXOSMITHKLINE IP DEV LTD0 citations47
US10457674B2Oct 29, 2019
Chemical compounds
GLAXOSMITHKLINE IP DEV LTD0 citations47